These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 15115524)

  • 1. Successful treatment of scleromyxoedema with high dose intravenous immunoglobulin.
    Karim A; Lawlor F; Black MM
    Clin Exp Dermatol; 2004 May; 29(3):317-8. PubMed ID: 15115524
    [No Abstract]   [Full Text] [Related]  

  • 2. Dementia associated with scleromyxoedema reversed by high-dose intravenous immunoglobulin.
    Shergill B; Orteu CH; McBride SR; Rustin MH
    Br J Dermatol; 2005 Sep; 153(3):650-2. PubMed ID: 16120159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial effect of granulocyte-colony stimulating factor in scleromyxoedema associated with severe idiopathic neutropenia.
    Cohen AM; Hodak E; David M; Mittelman M; Gal R; Stern R
    Br J Dermatol; 1996 Oct; 135(4):626-9. PubMed ID: 8915161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous immunoglobulins control scleromyxoedema.
    Righi A; Schiavon F; Jablonska S; Doria A; Blasczyk M; Rondinone R; Todesco S; Matucci Cerinic M
    Ann Rheum Dis; 2002 Jan; 61(1):59-61. PubMed ID: 11779761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful therapy of scleromyxoedema Arndt-Gottron with low-dose intravenous immunoglobulin.
    Körber A; Franckson T; Grabbe S; Dissemond J
    J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):553-4. PubMed ID: 17373996
    [No Abstract]   [Full Text] [Related]  

  • 6. Tumorous variant of scleromyxedema. Successful therapy with intravenous immunoglobulins.
    Wojas-Pelc A; Błaszczyk M; Glińska M; Jabłońska S
    J Eur Acad Dermatol Venereol; 2005 Jul; 19(4):462-5. PubMed ID: 15987294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arndt-Gottron scleromyxoedema: successful therapy with intravenous immunoglobulins.
    Gholam P; Hartmann M; Enk A
    Br J Dermatol; 2007 Nov; 157(5):1058-60. PubMed ID: 17854360
    [No Abstract]   [Full Text] [Related]  

  • 8. Koebner phenomenon due to scratch test in scleromyxoedema.
    Durani BK; Kurzen H; Hartschuh W; Naeher H
    Br J Dermatol; 2001 Aug; 145(2):306-8. PubMed ID: 11531798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scleromyxoedema: treatment of cutaneous and systemic manifestations with high-dose intravenous immunoglobulin.
    Kulczycki A; Nelson M; Eisen A; Heffernan M
    Br J Dermatol; 2003 Dec; 149(6):1276-81. PubMed ID: 14674909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scleroderma-like manifestation in a patient with primary systemic amyloidosis: response to high-dose intravenous immunoglobulin and plasma exchange.
    Cho SB; Park JS; Kim HO; Chung KY
    Yonsei Med J; 2006 Oct; 47(5):737-40. PubMed ID: 17066519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose intravenous immunoglobulin infusion as treatment for diffuse scleroderma.
    Ihn H; Mimura Y; Yazawa N; Jinnin M; Asano Y; Yamane K; Tamaki K
    Br J Dermatol; 2007 May; 156(5):1058-60. PubMed ID: 17381465
    [No Abstract]   [Full Text] [Related]  

  • 12. Case 5: extensive skin eruption causing skin to become tight, sore, and itchy. Diagnosis: scleromyxoedema.
    Karim A; Black MM; Lawlor F
    Clin Exp Dermatol; 2003 May; 28(3):343-4. PubMed ID: 12780738
    [No Abstract]   [Full Text] [Related]  

  • 13. Scleromyxoedema: clinical follow-up after successful treatment with high-dose immunoglobulins reveals different long-term outcomes.
    Bidier M; Zschoche C; Gholam P; Enk AH; Hadaschik EN
    Acta Derm Venereol; 2012 Jul; 92(4):408-9. PubMed ID: 22278389
    [No Abstract]   [Full Text] [Related]  

  • 14. Elephantiasic pretibial myxoedema with upper-limb involvement, treated with low-dose intravenous immunoglobulins.
    Dhaille F; Dadban A; Meziane L; Fessier C; Colta L; Lok C; Chaby G
    Clin Exp Dermatol; 2012 Apr; 37(3):307-8. PubMed ID: 22007759
    [No Abstract]   [Full Text] [Related]  

  • 15. Intravenous immunoglobulin treatment recovers the down-regulated levels of Th1 cytokines in the sera and skin of scleroderma patients.
    Kudo H; Jinnin M; Yamane K; Makino T; Kajihara I; Makino K; Honda N; Nakayama W; Fukushima S; Ihn H
    J Dermatol Sci; 2013 Jan; 69(1):77-80. PubMed ID: 23102713
    [No Abstract]   [Full Text] [Related]  

  • 16. [Mucinoses].
    Starzycki Z
    Przegl Lek; 1995; 52(4):141-4. PubMed ID: 7638361
    [No Abstract]   [Full Text] [Related]  

  • 17. Scleromyxedema: successful treatment of cutaneous and neurologic symptoms.
    Nieves DS; Bondi EE; Wallmark J; Raps EC; Seykora JT
    Cutis; 2000 Feb; 65(2):89-92. PubMed ID: 10696560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemophagocytic syndrome after autologous peripheral blood stem cell transplantation for multiple myeloma; successful treatment with high-dose intravenous immunoglobulin.
    Ostronoff M; Ostronoff F; Coutinho M; Calixto R; Souto Maior AP; Sucupira A; Florencio R; Tagliari C
    Bone Marrow Transplant; 2006 Apr; 37(8):797-8. PubMed ID: 16518425
    [No Abstract]   [Full Text] [Related]  

  • 19. Successful treatment of Clostridium difficile colitis with intravenous immunoglobulin.
    Koulaouzidis A; Tatham R; Moschos J; Tan CW
    J Gastrointestin Liver Dis; 2008 Sep; 17(3):353-5. PubMed ID: 18836636
    [No Abstract]   [Full Text] [Related]  

  • 20. Sclerodermatous changes of face, neck and scalp associated with familial porphyria cutanea tarda.
    Thomas CL; Badminton MN; Rendall JR; Anstey AV
    Clin Exp Dermatol; 2008 Jul; 33(4):422-4. PubMed ID: 18498414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.